Literature DB >> 11067937

Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides.

R I Tapping1, S Akashi, K Miyake, P J Godowski, P S Tobias.   

Abstract

Two members of the mammalian Toll-like receptor (TLR) family, TLR2 and TLR4, have been implicated as receptors mediating cellular activation in response to bacterial LPS. Through the use of mAbs raised against human TLR2 and TLR4, we have conducted studies in human cell lines and whole blood to ascertain the relative contribution of these receptors to LPS induced cytokine release. We show that the contribution of TLR2 and TLR4 to LPS-induced cellular activation correlates with the relative expression levels of these two TLRs in a given cell type. In addition, we have found that significant differences in cell stimulatory activity exist between various smooth and rough LPS types that cannot be ascribed to known LPS structural features. These results suggest that impurities in the LPS may be responsible for some of the activity and this would be in agreement with recently published results of others. Upon repurification, none of the commercial LPS preparations activate cells through TLR2, but continue to stimulate cells with comparable activity through TLR4. Our results confirm recent findings that TLR4, but not TLR2, mediates cellular activation in response to LPS derived from both Escherichia coli and Salmonella minnesota. Additionally, we show that TLR4 is the predominant signaling receptor for LPS in human whole blood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067937     DOI: 10.4049/jimmunol.165.10.5780

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  84 in total

1.  Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium.

Authors:  Elke Cario; Dennis Brown; Mary McKee; Kathryn Lynch-Devaney; Guido Gerken; Daniel K Podolsky
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Towards a physiology of epithelial pathogens.

Authors:  I Cook; A Young
Journal:  Pflugers Arch       Date:  2001-11-01       Impact factor: 3.657

3.  Synergic effects of mycoplasmal lipopeptides and extracellular ATP on activation of macrophages.

Authors:  Takeshi Into; Mari Fujita; Tsugumi Okusawa; Akira Hasebe; Manabu Morita; Ken-Ichiro Shibata
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

4.  Bacteroides fragilis-derived lipopolysaccharide produces cell activation and lethal toxicity via toll-like receptor 4.

Authors:  Giuseppe Mancuso; Angelina Midiri; Carmelo Biondo; Concetta Beninati; Maria Gambuzza; Daniele Macrì; Antonella Bellantoni; Andrej Weintraub; Terje Espevik; Giuseppe Teti
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

5.  A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo.

Authors:  Austin Pantel; Cheolho Cheong; Durga Dandamudi; Elina Shrestha; Saurabh Mehandru; Luke Brane; Darren Ruane; Angela Teixeira; Leonia Bozzacco; Ralph M Steinman; M Paula Longhi
Journal:  Eur J Immunol       Date:  2011-12-12       Impact factor: 5.532

Review 6.  Tracking the dynamics of T-cell activation in response to Salmonella infection.

Authors:  Rajesh Ravindran; Stephen J McSorley
Journal:  Immunology       Date:  2005-04       Impact factor: 7.397

7.  Attenuated Salmonella typhimurium reduces ovalbumin-induced airway inflammation and T-helper type 2 responses in mice.

Authors:  C-J Wu; L-C Chen; M-L Kuo
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

8.  Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease.

Authors:  K Nara; M S Kurokawa; S Chiba; H Yoshikawa; S Tsukikawa; T Matsuda; N Suzuki
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

9.  Macrophage-elicited osteoclastogenesis in response to bacterial stimulation requires Toll-like receptor 2-dependent tumor necrosis factor-alpha production.

Authors:  Takashi Ukai; Hiromichi Yumoto; Frank C Gibson; Caroline Attardo Genco
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

10.  Role of Toll-like receptors 2 and 4 in the induction of cyclooxygenase-2 in vascular smooth muscle.

Authors:  Rosario Jimenez; Elizabeth Belcher; Shiranee Sriskandan; Ruth Lucas; Shaun McMaster; Ivana Vojnovic; Timothy D Warner; Jane A Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.